RS49977B - Farmaceutske formulacije za aerosolove sa dve ili više aktivnih supstanci - Google Patents
Farmaceutske formulacije za aerosolove sa dve ili više aktivnih supstanciInfo
- Publication number
- RS49977B RS49977B YUP-800/00A YU80000A RS49977B RS 49977 B RS49977 B RS 49977B YU 80000 A YU80000 A YU 80000A RS 49977 B RS49977 B RS 49977B
- Authority
- RS
- Serbia
- Prior art keywords
- active substances
- aerosols
- pharmaceutical formulations
- active substance
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Farmaceutski preparat, za inhalatore sa potiskivanjem odmerene doze pomoću potisnog gasa, koji kao potisni gas sadrži fluorougljovodonik (HFC), koji sadrži kombinaciju dve ili vise aktivnih supstanci, naznačen time, što je bar jedna aktivna supstanca izabrana od ipratropijum bromida, fenoterola i njihovih soli prisutna u rastvorenom obliku, uz korišćenje korastvarača, zajedno sa bar jednom drugom aktivnom supstancorn, u obliku suspendovanih čestica, izabranom odsalbutamola (albuterola), hromoglicinske kiseline i njihovih soli. Prijava ima još 23 zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1998127178 DE19827178A1 (de) | 1998-06-18 | 1998-06-18 | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen |
DE1998142963 DE19842963A1 (de) | 1998-09-19 | 1998-09-19 | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen |
Publications (2)
Publication Number | Publication Date |
---|---|
YU80000A YU80000A (sh) | 2003-04-30 |
RS49977B true RS49977B (sr) | 2008-09-29 |
Family
ID=26046888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-800/00A RS49977B (sr) | 1998-06-18 | 1999-06-08 | Farmaceutske formulacije za aerosolove sa dve ili više aktivnih supstanci |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP1087750B1 (sr) |
JP (1) | JP2003522102A (sr) |
KR (1) | KR100600423B1 (sr) |
CN (1) | CN1161104C (sr) |
AR (1) | AR019690A1 (sr) |
AT (1) | ATE253896T1 (sr) |
AU (1) | AU759222B2 (sr) |
BG (1) | BG65252B1 (sr) |
BR (1) | BR9911351A (sr) |
CA (1) | CA2335065C (sr) |
CO (1) | CO5070580A1 (sr) |
CZ (1) | CZ300910B6 (sr) |
DE (1) | DE69912781T2 (sr) |
DK (1) | DK1087750T3 (sr) |
EE (1) | EE04450B1 (sr) |
ES (1) | ES2211108T3 (sr) |
HK (1) | HK1037974A1 (sr) |
HR (1) | HRP20000867B1 (sr) |
HU (1) | HU229064B1 (sr) |
ID (1) | ID27554A (sr) |
IL (2) | IL140353A0 (sr) |
ME (1) | ME00838B (sr) |
MY (1) | MY121073A (sr) |
NO (1) | NO329416B1 (sr) |
NZ (1) | NZ509418A (sr) |
PL (1) | PL193695B1 (sr) |
PT (1) | PT1087750E (sr) |
RS (1) | RS49977B (sr) |
RU (1) | RU2218152C2 (sr) |
SK (1) | SK284756B6 (sr) |
TR (1) | TR200003721T2 (sr) |
TW (1) | TW528606B (sr) |
WO (1) | WO1999065464A1 (sr) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
GB2332372B (en) * | 1997-12-08 | 2002-08-14 | Minnesota Mining & Mfg | Pharmaceutical aerosol compositions |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
US7214687B2 (en) | 1999-07-14 | 2007-05-08 | Almirall Ag | Quinuclidine derivatives and medicinal compositions containing the same |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317904B1 (it) | 1999-09-11 | 2003-07-15 | Glaxo Group Ltd | Formulazione farmaceutica di propionato di fluticasone. |
ATE286716T1 (de) * | 1999-11-23 | 2005-01-15 | Glaxo Group Ltd | Pharmazeutische formulierungen enthaltend salmeterol |
WO2001047493A1 (en) * | 1999-12-24 | 2001-07-05 | Glaxo Group Limited | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
GB0008485D0 (en) * | 2000-04-07 | 2000-05-24 | Glaxo Group Ltd | Pharmaceutical compositions |
SK286694B6 (sk) * | 2000-05-22 | 2009-03-05 | Chiesi Farmaceutici S.P.A. | Aerosólový farmaceutický prostriedok |
DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
DE10130371A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
US7652030B2 (en) | 2001-09-18 | 2010-01-26 | Nycomed Danmark Aps | Compositions for treatment of common cold |
JP2010184937A (ja) * | 2001-10-26 | 2010-08-26 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する1容器を作成する方法、および、吸入溶液を作成する方法 |
GB0207899D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
EP1915985A1 (en) * | 2003-03-20 | 2008-04-30 | Boehringer Ingelheim Pharmaceuticals Inc. | Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US9308199B2 (en) * | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
WO2006101882A2 (en) * | 2005-03-16 | 2006-09-28 | Honeywell International Inc. | Medicament delivery formulations, devices and methods |
DE102006053374A1 (de) * | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
DE102006017320A1 (de) | 2006-04-11 | 2007-10-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
US8061350B2 (en) | 2006-06-02 | 2011-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process and device for dosing pharmaceutical agents |
US20070286814A1 (en) * | 2006-06-12 | 2007-12-13 | Medispray Laboratories Pvt. Ltd. | Stable aerosol pharmaceutical formulations |
ES2298049B1 (es) | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano. |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2408500B1 (en) | 2009-03-17 | 2015-04-29 | Boehringer Ingelheim International GmbH | Dispensing device, and storage device for dispensing a formulation |
EP2414560B1 (de) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung einer oberfläche eines bauteils |
JP5763053B2 (ja) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アダプタ、吸入器具及びアトマイザ |
PE20130036A1 (es) | 2009-11-25 | 2013-02-03 | Boehringer Ingelheim Int | Nebulizador |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2512438B1 (en) | 2009-12-16 | 2017-01-25 | 3M Innovative Properties Company | Formulations and methods for controlling mdi particle size delivery |
JP5874724B2 (ja) | 2010-06-24 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
PL2835146T3 (pl) | 2013-08-09 | 2021-04-06 | Boehringer Ingelheim International Gmbh | Nebulizator |
ES2957901T3 (es) | 2014-05-07 | 2024-01-29 | Boehringer Ingelheim Int | Recipiente y dispositivo indicador y nebulizador |
CN106255554B (zh) | 2014-05-07 | 2021-05-04 | 勃林格殷格翰国际有限公司 | 容器、喷雾器及用途 |
DK3139984T3 (da) | 2014-05-07 | 2021-07-19 | Boehringer Ingelheim Int | Forstøver |
WO2020152548A1 (en) * | 2019-01-24 | 2020-07-30 | Glenmark Pharmaceuticals Limited | Stable aerosol inhalation compositions of formoterol |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
RU2126248C1 (ru) * | 1992-12-09 | 1999-02-20 | Берингер Ингельхейм Фармасьютикалз, Инк. | Жидкая фармацевтическая композиция в форме аэрозоля |
US5589156A (en) * | 1994-05-02 | 1996-12-31 | Henry; Richard A. | Prilocaine and hydrofluourocarbon aerosol preparations |
US5603918A (en) * | 1995-06-09 | 1997-02-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aerosol composition of a salt of ipratropium and a salt of albuterol |
EP0914143A1 (en) * | 1996-07-08 | 1999-05-12 | Rhone-Poulenc Rorer Limited | Medicinal cyclosporin-a aerosol solution formulation |
-
1999
- 1999-06-08 DE DE69912781T patent/DE69912781T2/de not_active Expired - Lifetime
- 1999-06-08 EE EEP200000759A patent/EE04450B1/xx unknown
- 1999-06-08 NZ NZ509418A patent/NZ509418A/xx not_active IP Right Cessation
- 1999-06-08 AT AT99928458T patent/ATE253896T1/de active
- 1999-06-08 RS YUP-800/00A patent/RS49977B/sr unknown
- 1999-06-08 AU AU45521/99A patent/AU759222B2/en not_active Expired
- 1999-06-08 RU RU2001101898/15A patent/RU2218152C2/ru active
- 1999-06-08 EP EP99928458A patent/EP1087750B1/en not_active Expired - Lifetime
- 1999-06-08 WO PCT/US1999/012785 patent/WO1999065464A1/en active IP Right Grant
- 1999-06-08 CZ CZ20004750A patent/CZ300910B6/cs not_active IP Right Cessation
- 1999-06-08 ID IDW20002641A patent/ID27554A/id unknown
- 1999-06-08 CN CNB99807439XA patent/CN1161104C/zh not_active Expired - Lifetime
- 1999-06-08 HU HU0104734A patent/HU229064B1/hu unknown
- 1999-06-08 IL IL14035399A patent/IL140353A0/xx active IP Right Grant
- 1999-06-08 JP JP2000554344A patent/JP2003522102A/ja active Pending
- 1999-06-08 KR KR1020007014407A patent/KR100600423B1/ko not_active IP Right Cessation
- 1999-06-08 PT PT99928458T patent/PT1087750E/pt unknown
- 1999-06-08 PL PL99345685A patent/PL193695B1/pl unknown
- 1999-06-08 SK SK1939-2000A patent/SK284756B6/sk unknown
- 1999-06-08 BR BR9911351-1A patent/BR9911351A/pt not_active Application Discontinuation
- 1999-06-08 CA CA002335065A patent/CA2335065C/en not_active Expired - Lifetime
- 1999-06-08 ME MEP-2000-800A patent/ME00838B/me unknown
- 1999-06-08 ES ES99928458T patent/ES2211108T3/es not_active Expired - Lifetime
- 1999-06-08 DK DK99928458T patent/DK1087750T3/da active
- 1999-06-08 TR TR2000/03721T patent/TR200003721T2/xx unknown
- 1999-06-15 TW TW088110010A patent/TW528606B/zh not_active IP Right Cessation
- 1999-06-16 MY MYPI99002491A patent/MY121073A/en unknown
- 1999-06-17 CO CO99037969A patent/CO5070580A1/es unknown
- 1999-06-18 AR ARP990102935A patent/AR019690A1/es active Pending
-
2000
- 2000-12-07 BG BG105033A patent/BG65252B1/bg active Active
- 2000-12-12 NO NO20006318A patent/NO329416B1/no not_active IP Right Cessation
- 2000-12-15 HR HR20000867A patent/HRP20000867B1/xx not_active IP Right Cessation
- 2000-12-15 IL IL140353A patent/IL140353A/en not_active IP Right Cessation
-
2001
- 2001-12-19 HK HK01108873A patent/HK1037974A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS49977B (sr) | Farmaceutske formulacije za aerosolove sa dve ili više aktivnih supstanci | |
RS49803B (sr) | Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa | |
EA200000823A1 (ru) | Способ и устройство для подачи действующего вещества в виде аэрозоли | |
ME00333B (me) | Farmaceutski aerosolni preparat | |
TR200101442T2 (tr) | HFA 227 ve HFA 137 ihtiva eden farmasötik aeorosol bileşimi | |
NO20025873L (no) | Meget effektiv levering av en stor terapeutisk mengde aerosol | |
RS50025B (sr) | Farmaceutski preparati koji mogu da budu gelirani | |
DK0799024T3 (da) | Farmaceutisk aerosol indeholdende mindst en sukker | |
RU94022269A (ru) | Состав аэрозоля, находящийся под давлением | |
NO954146L (no) | Belagte farmasöytiske preparater | |
RS52387B (sr) | Formoterol najfiniji preparat | |
EA199900991A1 (ru) | Медицинские аэрозольные препараты | |
KR900009057A (ko) | 의약용 에어로졸 제제 | |
RS49764B (sr) | Farmaceutski preparat za primenu na mukozu | |
DE69233150D1 (de) | Fluorchlorkohlenwasserstoffreie Aerosolformulierungen | |
IS4326A (is) | Ný forðakyrni og lyfjablanda sem inniheldur þau | |
IS1796B (is) | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband | |
DK1303258T3 (da) | Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle | |
TNSN01003A1 (fr) | Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes. | |
WO1999024016A8 (en) | Emulsions for aerosolization and drug delivery | |
JP2004026737A (ja) | 液状エアゾール剤用組成物 |